Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2010
11/04/2010WO2010080769A3 Chemotherapeutic methods and compositions
11/04/2010WO2010080188A3 Epitope targeted anthrax vaccine
11/04/2010WO2010079850A3 Agent for prophylaxis or treatment of cancer
11/04/2010WO2010079505A3 Combined measles-human papilloma vaccine
11/04/2010US20100280493 Methods and Systems for Treating Injured Cardiac Tissue
11/04/2010US20100280229 Polypeptide
11/04/2010US20100279386 Modified vaccinia ankara virus variant and cultivation method
11/04/2010US20100279325 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
11/04/2010US20100279307 Angiogenesis Inhibiting Molecules, Their Selection, Production and Their Use in the Treatment of Cancer
11/04/2010US20100278945 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
11/04/2010US20100278929 Antibody formulations having optimized aggregation and fragmentation profiles
11/04/2010US20100278924 Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
11/04/2010US20100278919 Dendritic cell targeting compositions and uses thereof
11/04/2010US20100278907 Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
11/04/2010US20100278904 Nucleotide vaccine
11/04/2010US20100278903 Prophylactic and immunomodulatory compositions and uses
11/04/2010US20100278896 Solid compositions
11/04/2010US20100278880 Pharmaceutical formulation for allergen preparation
11/04/2010US20100278874 Reagents and methods for cancer treatment and prevention
11/04/2010US20100278873 Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-cd3/cd28
11/04/2010US20100278872 Medicaments and methods for treating mesothelioma
11/04/2010US20100278871 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
11/04/2010US20100278870 Adenoviral vector-based malaria vaccines
11/04/2010US20100278869 Plant Produced Vaccine for Amebiasis
11/04/2010US20100278868 Codon-Optimized Dna Molecules Encoding the Receptor Binding Domains of Clostridium Difficile Toxins A and B, and Methods of Use Thereof
11/04/2010US20100278867 Use of botulinum toxin for the treatment of chronic facial pain
11/04/2010US20100278866 Borrelia diagnostics and screening methods
11/04/2010US20100278865 Production and use of epitope-tagged hepatitis c virus particle
11/04/2010US20100278864 Rabies Vaccine
11/04/2010US20100278863 Reoviruses
11/04/2010US20100278862 Nipah Virus Vaccines
11/04/2010US20100278861 Methods and compositions for predicting emergence and expansion of drug resistant strains of influenza virus
11/04/2010US20100278860 System and method for identifying complex patterns of amino acids
11/04/2010US20100278859 Diagnostic test kits
11/04/2010US20100278858 Process for preparing attenuated viral strains
11/04/2010US20100278857 Dendritic Cell Binding Proteins and Uses Thereof
11/04/2010US20100278856 BoNT/A PEPTIDES AND METHODSOF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY
11/04/2010US20100278854 Chlamydia antigens
11/04/2010US20100278853 Constrained hiv v3 loop peptides as novel immunogens and receptor antagonists
11/04/2010US20100278852 Antibodies against and methods for producing vaccines for respiratory syncytial virus
11/04/2010US20100278851 Ctl inducer composition
11/04/2010US20100278850 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
11/04/2010US20100278849 Prostatic acid phosphatase antigens
11/04/2010US20100278848 Tumor antigen bfy3 for prevention and/or treatment of cancer
11/04/2010US20100278847 Mutually suppressive gene/inhibitor combinations for non-antibiotic selection of recombinant strains
11/04/2010US20100278846 Nasal-administered vaccines using multi-screened nalt-targeting and phagocytic polypeptide transport sequences
11/04/2010US20100278845 Melanocortin Receptor Binding Conjugates
11/04/2010US20100278844 Cancer Marker and Therapeutic Target
11/04/2010US20100278843 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
11/04/2010US20100278842 Anti-ephb2 antibodies and methods using same
11/04/2010US20100278841 DOWN-REGULATION OF MORTALIN BY siRNA
11/04/2010US20100278840 Methods for treating rheumatoid arthritis using il-17 antagonists
11/04/2010US20100278839 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278837 Compositions And Methods For Reducing Cancer And Inflammation
11/04/2010US20100278836 Diagnostic and therapeutic methods and compositions for cardiovascular disease
11/04/2010US20100278835 Novel compounds 660
11/04/2010US20100278834 Antibodies against h5n1 strains of influenza a virus
11/04/2010US20100278833 Thiophene-imidazopyridines
11/04/2010US20100278832 Anti-bst2 antibody
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278830 Methods and systems for multi-antibody therapies
11/04/2010US20100278829 Dual inhibition of immunophilin/cyclophilin family members and emmprin immunoglobulin receptor superfamily members
11/04/2010US20100278828 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278826 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
11/04/2010US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods
11/04/2010US20100278824 Combinations comprising gemcitabine and tyrosine kinase inhibitors for the treatment of pancreatic cancer
11/04/2010US20100278823 Treatment of type 1 diabetes before and after expression of predisposition markers
11/04/2010US20100278822 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
11/04/2010US20100278821 N-cadherin: target for cancer diagnosis and therapy
11/04/2010US20100278820 Reagents that bind ccx-ckr2
11/04/2010US20100278819 Streptococcus pneumoniae vaccines
11/04/2010US20100278818 Antibody specific for the Tn antigen for the treatment of cancer
11/04/2010US20100278817 Compounds and methods for the treatment of renal disease
11/04/2010US20100278816 B7-dc binding antibody
11/04/2010US20100278815 Humanized Monoclonal Antibodies to Hepatocyte Growth Factor
11/04/2010US20100278814 Prevention and treatment of synucleinopathic and amyloidogenic disease
11/04/2010US20100278813 Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
11/04/2010US20100278812 Nasal immunization
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100278810 Methods of Modulating Angiogenesis
11/04/2010US20100278809 Inhibitors of MRP4 for the Treatment of Vascular Disorders
11/04/2010US20100278808 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
11/04/2010US20100278807 Novel antimicrobial agents
11/04/2010US20100278779 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
11/04/2010US20100278773 Chimeric flavivirus vaccines
11/04/2010US20100278772 Dna methylation markers and methods of use
11/04/2010US20100278752 Methods for Detection and Prevention of Tick Infestation and Pathogen Transmission
11/04/2010US20100278742 Methods and compositions for detection and diagnosis of infectious diseases
11/04/2010US20100278740 Streptococcus pneumoniae proteins and nucleic acid molecules
11/04/2010US20100278736 FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy
11/04/2010US20100278729 Breast cancer eradication program
11/04/2010US20100278728 Anti-Mullerian Inhibiting Substance Type II Receptor (MISIIR) Immunoconjugates to Detect and Treat Cancer
11/04/2010US20100278724 Inhibition of migration and induction of cell death by the type ii collagen amino propeptides
11/04/2010CA2764432A1 Anti-il-3ra antibody for use in treatment of blood tumor
11/04/2010CA2763816A1 Adjuvanted vaccines for protecting against influenza
11/04/2010CA2760687A1 Methods for treating or preventing ophthalmological diseases
11/04/2010CA2760642A1 Anti-cadherin antibody
11/04/2010CA2760525A1 Toll-like receptor 3 antagonists
1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 1823